The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species-Reference-Cited by-同舟云学术

The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species

Published:2001-09-04 Issue:19 Volume:98 Page:10833-10838
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Ruefli A. A.,Ausserlechner M. J.,Bernhard D.,Sutton V. R.,Tainton K. M.,Kofler R.,Smyth M. J.,Johnstone R. W.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference39 articles.

1. Apoptosis and therapy

2. Two Distinct Pathways Leading to Nuclear Apoptosis

3. Apoptotic Pathways

4. Fas-induced Apoptosis.

5. Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis

Cited by 450 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploration of Hydrazide-Based HDAC8 PROTACs for the Treatment of Hematological Malignancies and Solid Tumors;Journal of Medicinal Chemistry;2024-08-01

2. HDAC inhibitors activate lipid peroxidation and ferroptosis in gastric cancer;Biochemical Pharmacology;2024-07

3. Quisinostat is a brain-penetrant radiosensitizer in glioblastoma;JCI Insight;2023-11-22

4. Molecular Docking of Andrographoilde and HDAC2 inhibitor an approach to manage for Beta Thalassemia;Research Journal of Pharmacy and Technology;2023-09-30

5. Selective HDAC3 Inhibitors with Potent In Vivo Antitumor Efficacy against Triple-Negative Breast Cancer;Journal of Medicinal Chemistry;2023-09-03